Case Report: Exacerbation of varices following atezolizumab plus bevacizumab treatment of hepatocellular carcinoma: A case series and literature review

Recently, a combined regimen of atezolizumab and bevacizumab (AB) treatment has been approved as a first-line treatment in patients with advanced hepatocellular carcinoma (HCC), contributing to prolonged survival. However, we often encounter cases where treatment must be discontinued due to the occu...

Descripción completa

Detalles Bibliográficos
Autores principales: Suzuki, Hiroyuki, Iwamoto, Hideki, Shimose, Shigeo, Niizeki, Takashi, Shirono, Tomotake, Noda, Yu, Kamachi, Naoki, Yamaguchi, Taizo, Nakano, Masahito, Kuromatsu, Ryoko, Koga, Hironori, Kawaguchi, Takumi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9355247/
https://www.ncbi.nlm.nih.gov/pubmed/35936693
http://dx.doi.org/10.3389/fonc.2022.948293

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9355247/
https://www.ncbi.nlm.nih.gov/pubmed/35936693
http://dx.doi.org/10.3389/fonc.2022.948293

Ejemplares similares